Gary Chi
0009-0003-5374-4214
2 papers found
Refreshing results…
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
Missing publications? Search for publications with a matching author name.